{"id":"W3030083314","doi":"10.1200/jco.2020.38.15_suppl.102","title":"Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fludarabine; Neutropenia; Leukopenia; Cyclophosphamide; Internal medicine; Febrile neutropenia; Regimen; Gastroenterology; Chemotherapy; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004259082,0.0001007421,0.001267391,0.00009396355,0.00002565511,0.000008157223,0.0001174427,0.0001811253,0.0001962891],"category_scores_gemma":[0.005700211,0.0000630215,0.0001690224,0.0002110567,0.0001837552,0.00007630578,0.00008667918,0.0009380001,0.000003107118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005873518,"about_ca_system_score_gemma":0.0006161389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005905329,"about_ca_topic_score_gemma":0.000009490154,"domain_scores_codex":[0.9964732,0.0007491122,0.002025925,0.0001888823,0.0003880369,0.0001748545],"domain_scores_gemma":[0.9939969,0.00446536,0.000752274,0.0001402819,0.0002067867,0.000438421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.406725,0.001855839,0.001317089,0.00002995544,0.00006476665,0.0001983997,0.0005970068,0.00008838408,0.1031509,0.00001164829,0.0002123744,0.4857486],"study_design_scores_gemma":[0.6141363,0.1541749,0.1580709,0.0003419631,0.000259045,0.0001602823,0.0007653257,0.002622953,0.01140664,0.0001197039,0.05773987,0.0002020134],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856644,0.0001425122,0.0001865639,0.01262118,0.0003085747,0.000686261,0.000002517286,0.000003310118,0.0003847201],"genre_scores_gemma":[0.9956397,0.0009943388,0.001009994,0.001323366,0.0009469901,0.00000183463,0.000001086344,0.00001292334,0.00006972722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4855466,"threshold_uncertainty_score":0.6824096,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2037260286482502,"score_gpt":0.5361714243604768,"score_spread":0.3324453957122266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}